Showing results (11-20 of 86) with videos related to
Sort By:
Pageof 9
Current Pharmaceutical Design|December 24, 2009
Human A3 adenosine receptor as versatile G protein-coupled receptor example to validate the receptor homology modeling technologyErika Morizzo, Stephanie Federico, Giampiero Spalluto, et al.European Journal of Medicinal Chemistry|December 4, 2003
Fullerene derivatives: an attractive tool for biological applicationsSusanna Bosi, Tatiana Da Ros, Giampiero Spalluto, et al.Cells|October 28, 2025
Adenosine Receptors in Neuroinflammation and NeurodegenerationVeronica Salmaso, Silvia Menin, Stefano Moro, et al.Trends in Pharmacological Sciences|November 6, 2015
Advances in Computational Techniques to Study GPCR-Ligand RecognitionAntonella Ciancetta, Davide Sabbadin, Stephanie Federico, et al.Current Medicinal Chemistry|February 16, 2022
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative DiseasesTeresa Gianferrara, Eleonora Cescon, Ilenia Grieco, et al.Medicinal Research Reviews|December 29, 2005
Progress in the pursuit of therapeutic adenosine receptor antagonistsStefano Moro, Zhan-Guo Gao, Kenneth A Jacobson, et al.Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Synthesis and anti-HIV properties of new water-soluble bis-functionalized[60]fullerene derivativesSusanna Bosi, Tatiana Da Ros, Giampiero Spalluto, et al.British Journal of Pharmacology|January 18, 2006
A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitroAnna Maria Pugliese, Elisabetta Coppi, Giampiero Spalluto, et al.Bioorganic & Medicinal Chemistry Letters|June 28, 2005
Anti-HIV properties of cationic fullerene derivativesSilvia Marchesan, Tatiana Da Ros, Giampiero Spalluto, et al.International Journal of Molecular Sciences|May 14, 2022
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?Davide Bassani, Matteo Pavan, Stephanie Federico, et al.Pageof 9